Charles Schwab
VAXX

Charles Schwab’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Charles Schwab’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-120,334
Closed -$86.3K – 3721
2024
Q1 		$86.3K Hold
120,334
– – ﹤0.01% 3319
2023
Q4 		$102K Hold
120,334
– – ﹤0.01% 3344
2023
Q3 		$165K Hold
120,334
– – ﹤0.01% 3312
2023
Q2 		$303K Buy
120,334
+97,417
+425% +$206K ﹤0.01% 3226
2023
Q1 		$52K Hold
22,917
– – ﹤0.01% 3341
2022
Q4 		$32.1K Hold
22,917
– – ﹤0.01% 3446
2022
Q3 		$46K Buy
+22,917
New +$47.7K ﹤0.01% 3348

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Charles Schwab's VAXX Position: Q2 2024 in Review

Charles Schwab sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 120,334 shares — an estimated $86.3K sold.

Charles Schwab first reported a position in VAXX in Q3 2022 and held it in 7 quarters. The position peaked at $303K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Charles Schwab reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 120,334 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $86.3K.
  • Charles Schwab first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2022 and held it in 7 quarters.
  • Charles Schwab's Vaxxinity, Inc. Class A Common Stock position peaked at $303K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.